Characterization of mutations in streptomycin-resistant Mycobacterium tuberculosis clinical isolates in the area of Barcelona

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 11, 2010, Pages 2341-2346

  Tudó, Griselda ^a   Rey, Emma ^a   Borrell, Sònia ^a   Alcaide, Fernando ^b   Codina, Gemma ^c   Coll, Pere ^d   Martín Casabona, Núria ^c   Montemayor, Michel ^d   Moure, Raquel ^b   Orcau, Àngels ^e   Salvadó, Margarita ^f   Vicente, Eva ^f   González Martín, Juliá ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

^f Laboratori de Referencia de Catalunya   (Spain)

Author keywords

M. tuberculosis; RpsL; Rrs; Streptomycin resistance

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CODON; DNA SEQUENCE; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; MUTATIONAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RPSL GENE; RRS GENE; SPAIN;

ANTITUBERCULAR AGENTS; BACTERIAL TYPING TECHNIQUES; DNA FINGERPRINTING; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; MYCOBACTERIUM TUBERCULOSIS; RIBOSOMAL PROTEINS; SPAIN; STREPTOMYCIN; TUBERCULOSIS;

EID: 77957879827     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq322     Document Type: Article

References (32)

1. British Medical Research Council. Streptomycin treatment of pulmonary tuberculosis. A Medical Research Council Investigation. BMJ 1948; 2: 769-82.
2. World Health Organization/International Union against Tuberculosis and Lung Disease. Anti-tuberculosis Drug Resistance in the World, Fourth Global Report. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance, 2002-2007. WHO/HTM/TB/2008.394. Geneva: WHO, 2008.
3. La tuberculosi a Barcelona. Informe 2008. Programa de Prevencioí Control de la Tuberculosi de Barcelona. Ageńcia de Salut Pública de Barcelona, Barcelona, 2009. http://www.aspb.es/quefem/documents.htm (May 2010, date last accessed).
4. Martin-Casabona N, Alcaide F, Coll P et al. [Drug resistance in Mycobacterium tuberculosis. A multicenter study of the Barcelona area. Grupo de Trabajo sobre Resistencias en Tuberculosis.] Med Clin (Barc) 2000; 115: 493-8.
5. Borell S, Espanõl M, Orcau A et al. Tuberculosis transmission patterns among Spanish-born and foreign-born populations in the city of Barcelona. Clin Microbiol Infect 2010; 16: 568-74.
6. Winder FG. Model of action of the antimycobacterial agents and associated aspects of the molecular biology of mycobacteria. In: Ratledge L, Stanford J, eds. The Biology of the Mycobacteria, Vol. 1. New York, NY: Academic Press, Inc., 1982; 353-438.
7. Finken M, Kirschner P, Meier A et al. Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S1gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Mol Microbiol 1993; 9: 1239-46.
8. Honoré N, Cole ST. Streptomycin resistance in mycobacteria. Antimicrob Agents Chemother 1994; 38: 238-42.
9. Dobner P, Bretzel G, Rusch-Gerdes S et al. Geographic variation of the predictive values of genomic mutations associated with streptomycin resistance in Mycobacterium tuberculosis. Mol Cell Probes 1997; 11: 123-6.
10. Katsukawa C, Tamaru A, Miyata Y et al. Characterization of the rpsL and rrs genes of streptomycin-resistant clinical isolates of Mycobacterium tuberculosis in Japan. J Appl Microbiol 1997; 83: 634-40.
11. Brzostek A, Sajduda A, Sliwinski T et al. Molecular characterisation of streptomycin-resistant Mycobacterium tuberculosis strains isolated in Poland. Int J Tuberc Lung Dis 2004; 8: 1038-5.
12. Ramaswamy SV, Dou SJ, Rendon A et al. Genotype analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. J Med Microbiol 2004; 53: 107-13.
13. Shi R, Zhang J, Li C et al. Detection of streptomycin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by denaturing HPLC analysis and DNA sequencing. Microbes Infect 2007; 9: 1538-44.
14. Sandgren A, Strong M, Muthukrishana P et al. Tuberculosis drug resistance mutation database. PLoS Med 2009; 6: e1000002. doi:10.1971/jounal.pmed.1000002
15. Meier A, Kirschner P, Bange FC et al. Genetic alterations in streptomycin-resistant Mycobacterium tuberculosis: mapping of mutations conferring resistance. Antimicrob Agents Chemother 1994; 38: 228-33.
16. Sreevatsan S, Pan X, Stockbauer K et al. Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities. Antimicrob Agents Chemother 1996; 40: 1024-6.
17. Cooksey R, Morlock GP, McQueen A et al. Characterization of streptomycin resistance mechanism among Mycobacterium tuberculosis isolates from patients in New York City. Antimicrob Agents Chemother 1996; 5: 1186-8.
18. Meier A, Sander P, Schaper KJ et al. Correlation of molecular resistance mechanisms and phenotypic resistance levels in streptomycin-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 1996; 40: 2452-4.
19. Fukuda M, Koga H, Ohno H et al. Relationship between genetic alterations of the rpsL gene and streptomycin susceptibility of Mycobacterium tuberculosis in Japan. J Antimicrob Chemother 1999; 43: 281-4.
20. Brudey K, Driscoll JR, Rigouts L et al. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 2006; 6: 23.
21. Lipin MY, Stepanshina VN, Shemyakin IG et al. Association of specific mutations in katG, rpoB, rpsL and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia. Clin Microbiol Infect 2007; 13: 620-6.
22. Perdigao J, Macedo R, Joao I et al. Multidrug-resistant tuberculosis in Lisbon, Portugal: a molecular epidemiological perspective. Microb Drug Resist 2008; 14: 133-43.
23. Sun YJ, Luo JT, Wong SY et al. Analysis of rpsL and rrs mutations in Beijing and non-Beijing streptomycin-resistant Mycobacterium tuberculosis isolates from Singapore. Clin Microbiol Infect 2010; 16: 287-9.
24. Woods GL, Warren NG, Inderlied CB. Susceptibility test methods: Mycobacteria, Nocardia, and other Actinomycetes. In: Murray PR, Baron EJ, Pfaller MA et al., eds. Manual of Clinical Microbiology, 9th edn. Washington, DC: American Society for Microbiology, 2007; 1223-47.
25. Bemer P, Palicova F, Rüsch-GerdesS et al. Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 96system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 2002; 40: 150-4.
26. Kamerbeek J, Schouls L, Kolk A et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997; 35: 407-14.
27. van Embdem JD, Cave MD, Crewford JT et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting recommendations for a standardized methodology. J Clin Microbiol 1993; 31: 406-9.
28. Siddiqi N, Shamin M, Hussain S et al. Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India. Antimicrob Agents Chemother 2002; 46: 443-50.
29. Tracevska T, Jansone I, Nodieva A et al. Characterisation or rpsL, rrs and embB mutations associated with streptomycin and ethambutol resistance in Mycobacterium tuberculosis. Res Microbiol 2007; 155: 830-4.
30. Spies FS, Almeida da Silva PE, Ribeiro MO et al. Identification of mutations related to streptomycin resistance in clinical isolates of Mycobacterium tuberculosis and possible involvement of efflux mechanism. Antimicrob Agents Chemother 2008; 52: 2947-9.
31. Victor TC, van Rie A, Jordaan AM et al. Sequence polymorphism in the rrs gene of Mycobacterium tuberculosis is deeply rooted within an evolutionary clade and is not associated with streptomycin resistance. J Clin Microbiol 2001; 39: 4184-6.
32. Glynn JR, Whiteley J, Bifani PJ et al. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 2002; 8: 843-9.